The Claim
Lower body mass index (BMI) is associated with a suboptimal reduction in low-density lipoprotein (LDL) cholesterol levels in response to statin therapy among adults diagnosed with primary hypercholesterolemia.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
Adults with primary hypercholesterolemia who have a lower body mass index experience a smaller decrease in LDL cholesterol when taking statins compared to those with higher body mass index.
See the scientific wording
Lower body mass index (BMI) is associated with a suboptimal LDL cholesterol reduction response to statin therapy in adults with primary hypercholesterolemia.
In people with lower body weight, the liver produces fewer receptors that grab LDL cholesterol from the blood. Statins try to increase these receptors, but they cannot fully overcome the low baseline level, so LDL cholesterol stays higher than in heavier people.
What the research says
1 studyThe study found that thinner people tended to get less benefit from statin drugs in lowering their bad cholesterol compared to heavier people, which matches the claim.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.